scispace - formally typeset
Search or ask a question

Showing papers by "Francesca Moro published in 2004"


Journal ArticleDOI
TL;DR: Mutation analysis of FLN1 should support genetic counseling in men with periventricular nodular heterotopia and is caused by different genetic mechanisms, including somatic mosaicism.
Abstract: Objective: To describe the phenotypic spectrum and genetics of periventricular nodular heterotopia (PNH) caused by FLN1 mutations in four men. Background: X-linked PNH caused by FLN1 mutations (MIM #300049) implies prenatal or early postnatal lethality in boys and 50% recurrence risk in daughters of affected women. Methods: Clinical examination, cognitive testing, MRI, and mutation analysis (denaturing high-performance liquid chromatography and direct sequencing) on blood lymphocytes and single hair roots were performed for nine affected individuals, including three men. Neuropathologic study of the brain was performed for an affected boy. Results: In two families, missense mutations were transmitted from mother to son (Met102Val) and from father to daughter (Ser149Phe), causing mild phenotypes in both genders, including unilateral PNH. In a third family, a man was mosaic for an A>G substitution (intron 11 acceptor splice site) on leukocyte DNA and hair roots (mutant = 42% and 69%). Single hair root analysis confirmed that the mutation was not present in all ectodermal derivative cells. A healthy daughter had inherited the X chromosome from her father’s wild-type germinal cell population. In the fourth family, an eight-base deletion (AGGAGGTG, intron 25 donor splice site) led to early deaths of boys. Postmortem study in a newborn boy revealed PNH and cardiovascular, genitourinary, and gut malformations. Conclusions: Periventricular nodular heterotopia caused by FLN1 mutations in men has a wide clinical spectrum and is caused by different genetic mechanisms, including somatic mosaicism. Mutation analysis of FLN1 should support genetic counseling in men with periventricular nodular heterotopia.

127 citations


Journal ArticleDOI
TL;DR: Seven Italian families with generalized epilepsy with febrile seizures plus (GEFS+), in which mutations of SCN1A,SCN1B, and GABRG2 genes were excluded, are described and their clinical spectrum is compared with that of previously reported GEFS+ with known mutations.
Abstract: Summary: Purpose: We describe seven Italian families with generalized epilepsy with febrile seizures plus (GEFS+), in which mutations of SCN1A, SCN1B, and GABRG2 genes were excluded and compare their clinical spectrum with that of previously reported GEFS+ with known mutations. Methods: We performed a clinical study of seven families (167 individuals). The molecular study included analysis of polymerase chain reaction (PCR) fragments of SCN1A and SCN1B exons by denaturing high-performance liquid chromatography (DHPLC) and direct sequencing of GABRG2 in all families. We excluded SCN1A, SCN1B, and GABRG2 genes with linkage analysis in a large pedigree and directly sequenced SCN2A in a family with neonatal–infantile seizures onset. We compared the epilepsy phenotypes observed in our families with those of GEFS+ families harboring mutations of SCN1A, SCN1B, and GABRG2 and estimated the percentage of mutations of these genes among GEFS+ cases by reviewing all published studies. Results: Inheritance was autosomal dominant with 69% penetrance. Forty-one individuals had epilepsy: 29 had a phenotype consistent with GEFS+; seven had idiopathic generalized epilepsy (IGE); in three, the epilepsy type could not be classified; and two were considered phenocopies. Clinical phenotypes included FS+ (29.2%), FS (29.2%), IGE (18.2%), FS+ with focal seizures (13%) or absence seizures (2.6%), and FS with absence seizures (2.6%). Molecular study of SCN1A, SCN2A, SCN1B, and GABRG2 did not reveal any mutation. Results of our study and literature review indicate that mutations of SCN1A, SCN2A, SCN1B, and GABRG2 in patients with GEFS+ are rare. Conclusions: The most frequently observed phenotypes matched those reported in families with mutations of the SCN1A, SCN1B, and GABRG2 genes. IGE and GEFS+ may overlap in some families, suggesting a shared genetic mechanism. The observation that 13% of affected individuals had focal epilepsy confirms previously reported rates and should prompt a reformulation of the “GEFS+” concept to include focal epileptogenesis.

65 citations


01 Jan 2004
TL;DR: In this paper, the authors describe seven Italian families with generalized epilepsy with febrile seizures plus (GEFS + ), in which mutations of SCN1A, SCN 1B, and GABRG2 genes wereexcluded and compare their clinical spectrum with that of pre-viously reported GEFS+ with known mutations.
Abstract: Summary: Purpose: We describe seven Italian families withgeneralized epilepsy with febrile seizures plus (GEFS + ), inwhich mutations of SCN1A, SCN1B, and GABRG2 genes wereexcluded and compare their clinical spectrum with that of pre-viously reported GEFS + with known mutations. Methods: We performed a clinical study of seven families(167individuals).Themolecularstudyincludedanalysisofpoly-merase chain reaction (PCR) fragments of SCN1A and SCN1B exons by denaturing high-performance liquid chromatography(DHPLC) and direct sequencing of GABRG2 in all families.We excluded SCN1A, SCN1B , and GABRG2 genes with linkageanalysis in a large pedigree and directly sequenced SCN2A ina family with neonatal–infantile seizures onset. We comparedthe epilepsy phenotypes observed in our families with those ofGEFS + families harboring mutations of SCN1A, SCN1B , and GABRG2 and estimated the percentage of mutations of thesegenes among GEFS + cases by reviewing all published studies. Results : Inheritance was autosomal dominant with 69% pen-etrance. Forty-one individuals had epilepsy: 29 had a pheno-type consistent with GEFS